The Adiponectin-AdipoR1 Axis Mediates Tumor Progression and Tyrosine Kinase Inhibitor Resistance in Metastatic Renal Cell Carcinoma

The survival of patients diagnosed with metastatic renal cell carcinoma (RCC) is still limited and the current targeted therapies are only partially effective. Herein, we investigated the clinical value and functions of adiponectin receptors (AdipoR1 and AdipoR2) in metastatic renal cell carcinoma (...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neoplasia
Autori principali: Sun, Guangxi, Zhang, Xingming, Liu, Zhenhua, Zhu, Sha, Shen, Pengfei, Zhang, Haoran, Zhang, Mengni, Chen, Ni, Zhao, Jinge, Chen, Junru, Liu, Jiandong, Dai, Jindong, Wang, Zhipeng, Zhu, Xudong, Wang, Yufang, Zeng, Hao
Natura: Artigo
Lingua:Inglês
Pubblicazione: Neoplasia Press 2019
Soggetti:
Original article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6700451/
https://ncbi.nlm.nih.gov/pubmed/31401413
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2019.07.004
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi